cilostazol has been researched along with Heart Failure in 9 studies
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In the last few years, cilostazol, a phosphodiesterase (PDE) 3 inhibitor, has been tested in the setting of acute coronary syndromes: it exerts not only anti-platelet actions, but also pleiotropic effects, including inhibition on neointimal hyperplasia, therefore preventing both stent restenosis and thrombosis." | 4.88 | Cilostazol and primary-PCI: mirage or good alternative? ( Crea, F; D'Amario, D; Porto, I, 2012) |
| "Cilostazol is a selective phosphodiesterase 3 (PDE3) inhibitor approved by the Food and Drug Administration for treatment of intermittent claudication." | 2.47 | Effects of cilostazol in the heart. ( Chattipakorn, N; Chattipakorn, S; Kanlop, N, 2011) |
| "Cilostazol was not associated with an increase in any arrhythmic complication." | 1.39 | Practice-based evidence: profiling the safety of cilostazol by text-mining of clinical notes. ( Bauer-Mehren, A; Iyer, SV; Leeper, NJ; Lependu, P; Olson, C; Shah, NH, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reddy, SS | 1 |
| Agarwal, H | 1 |
| Barthwal, MK | 1 |
| Leeper, NJ | 1 |
| Bauer-Mehren, A | 1 |
| Iyer, SV | 1 |
| Lependu, P | 1 |
| Olson, C | 1 |
| Shah, NH | 1 |
| Tara, S | 1 |
| Kurobe, H | 1 |
| de Dios Ruiz Rosado, J | 1 |
| Best, CA | 1 |
| Shoji, T | 1 |
| Mahler, N | 1 |
| Yi, T | 1 |
| Lee, YU | 1 |
| Sugiura, T | 1 |
| Hibino, N | 1 |
| Partida-Sanchez, S | 1 |
| Breuer, CK | 1 |
| Shinoka, T | 1 |
| Otoshi, T | 1 |
| Kataoka, Y | 1 |
| Nakagawa, A | 1 |
| Otsuka, K | 1 |
| Tomii, K | 1 |
| Kanlop, N | 1 |
| Chattipakorn, S | 1 |
| Chattipakorn, N | 1 |
| Porto, I | 1 |
| D'Amario, D | 1 |
| Crea, F | 1 |
| Hondo, T | 1 |
| Matsumura, H | 1 |
| Matsuda, K | 1 |
| Iwamoto, A | 1 |
| Eno, S | 1 |
| Kimura, M | 1 |
| Bertelli, L | 1 |
| Amato, A | 1 |
| Sangiorgi, GM | 1 |
| Sanganalmath, SK | 1 |
| Barta, J | 1 |
| Takeda, N | 1 |
| Kumamoto, H | 1 |
| Dhalla, NS | 1 |
2 reviews available for cilostazol and Heart Failure
| Article | Year |
|---|---|
Effects of cilostazol in the heart.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cilostazol; Heart Conduction System; Heart Failure; He | 2011 |
Cilostazol and primary-PCI: mirage or good alternative?
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Arrhythmias, Cardiac; Aspirin; Cilostazol; | 2012 |
7 other studies available for cilostazol and Heart Failure
| Article | Year |
|---|---|
Cilostazol ameliorates heart failure with preserved ejection fraction and diastolic dysfunction in obese and non-obese hypertensive mice.
Topics: Angiotensin II; Animals; Biomarkers; Biopsy; Blood Pressure; Cilostazol; Diastole; Disease Models, A | 2018 |
Practice-based evidence: profiling the safety of cilostazol by text-mining of clinical notes.
Topics: Aged; Aged, 80 and over; Cilostazol; Cohort Studies; Data Mining; Female; Heart Failure; Humans; Mal | 2013 |
Cilostazol, Not Aspirin, Prevents Stenosis of Bioresorbable Vascular Grafts in a Venous Model.
Topics: Absorbable Implants; Animals; Aspirin; Blood Vessel Prosthesis; Cell Proliferation; Cilostazol; Dise | 2015 |
Clinical Features and Outcomes of Diffuse Alveolar Hemorrhage During Antithrombotic Therapy: A Retrospective Cohort Study.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Cilostazol; Clopidogrel; Connective Tissue Diseases; Female | 2016 |
A case of acute coronary artery occlusion associated with very rapid onset heparin-induced thrombosis without thrombocytopenia.
Topics: Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Aspirin; Autoantibodies | 2012 |
Treatment of superficial and profunda femoral artery bifurcation lesions: still a procedure only for surgeons?
Topics: Aged; Atherosclerosis; Catheters; Chronic Disease; Cilostazol; Coronary Artery Bypass; Coronary Arte | 2012 |
Antiplatelet therapy mitigates cardiac remodeling and dysfunction in congestive heart failure due to myocardial infarction.
Topics: Animals; Arrhythmias, Cardiac; Cilostazol; Disease Models, Animal; Echocardiography; Electrocardiogr | 2008 |